MOLECULAR PARTNERS N revenue for the last year amounted to 5.00 M CHF, the most of which — 4.97 M CHF — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 7.04 M CHF. The greatest contribution to the revenue figure was made by Switzerland — last year it brought MOLECULAR PARTNERS N 4.97 M CHF, and the year before that — 7.04 M CHF.